SMMNY
Price
$27.48
Change
-$0.36 (-1.29%)
Updated
Jul 3 closing price
Capitalization
65B
26 days until earnings call
SSMXF
Price
$16.00
Change
-$1.10 (-6.43%)
Updated
Jul 3 closing price
Capitalization
14.31B
Interact to see
Advertisement

SMMNY vs SSMXF

Header iconSMMNY vs SSMXF Comparison
Open Charts SMMNY vs SSMXFBanner chart's image
Siemens Healthineers AG
Price$27.48
Change-$0.36 (-1.29%)
Volume$15.18K
Capitalization65B
Sysmex
Price$16.00
Change-$1.10 (-6.43%)
Volume$105
Capitalization14.31B
SMMNY vs SSMXF Comparison Chart in %
Loading...
SMMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SMMNY vs. SSMXF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMMNY is a Buy and SSMXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (SMMNY: $27.48 vs. SSMXF: $16.00)
Brand notoriety: SMMNY and SSMXF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SMMNY: 17% vs. SSMXF: 7%
Market capitalization -- SMMNY: $65B vs. SSMXF: $14.31B
SMMNY [@Medical Specialties] is valued at $65B. SSMXF’s [@Medical Specialties] market capitalization is $14.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SMMNY’s FA Score shows that 1 FA rating(s) are green whileSSMXF’s FA Score has 1 green FA rating(s).

  • SMMNY’s FA Score: 1 green, 4 red.
  • SSMXF’s FA Score: 1 green, 4 red.
According to our system of comparison, SMMNY is a better buy in the long-term than SSMXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SMMNY’s TA Score shows that 5 TA indicator(s) are bullish while SSMXF’s TA Score has 2 bullish TA indicator(s).

  • SMMNY’s TA Score: 5 bullish, 3 bearish.
  • SSMXF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, SMMNY is a better buy in the short-term than SSMXF.

Price Growth

SMMNY (@Medical Specialties) experienced а +0.27% price change this week, while SSMXF (@Medical Specialties) price change was +6.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

SMMNY is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMNY($65B) has a higher market cap than SSMXF($14.3B). SSMXF has higher P/E ratio than SMMNY: SSMXF (42.74) vs SMMNY (38.76). SMMNY YTD gains are higher at: 6.226 vs. SSMXF (-17.184). SSMXF has higher annual earnings (EBITDA): 102B vs. SMMNY (3.79B). SSMXF has more cash in the bank: 70.3B vs. SMMNY (1.75B). SMMNY has less debt than SSMXF: SMMNY (654M) vs SSMXF (22.6B). SSMXF has higher revenues than SMMNY: SSMXF (411B) vs SMMNY (21.6B).
SMMNYSSMXFSMMNY / SSMXF
Capitalization65B14.3B455%
EBITDA3.79B102B4%
Gain YTD6.226-17.184-36%
P/E Ratio38.7642.7491%
Revenue21.6B411B5%
Total Cash1.75B70.3B2%
Total Debt654M22.6B3%
FUNDAMENTALS RATINGS
SMMNY vs SSMXF: Fundamental Ratings
SMMNY
SSMXF
OUTLOOK RATING
1..100
2981
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
17
Undervalued
PROFIT vs RISK RATING
1..100
73100
SMR RATING
1..100
64100
PRICE GROWTH RATING
1..100
5154
P/E GROWTH RATING
1..100
8276
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SMMNY's Valuation (8) in the null industry is in the same range as SSMXF (17). This means that SMMNY’s stock grew similarly to SSMXF’s over the last 12 months.

SMMNY's Profit vs Risk Rating (73) in the null industry is in the same range as SSMXF (100). This means that SMMNY’s stock grew similarly to SSMXF’s over the last 12 months.

SMMNY's SMR Rating (64) in the null industry is somewhat better than the same rating for SSMXF (100). This means that SMMNY’s stock grew somewhat faster than SSMXF’s over the last 12 months.

SMMNY's Price Growth Rating (51) in the null industry is in the same range as SSMXF (54). This means that SMMNY’s stock grew similarly to SSMXF’s over the last 12 months.

SSMXF's P/E Growth Rating (76) in the null industry is in the same range as SMMNY (82). This means that SSMXF’s stock grew similarly to SMMNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SMMNYSSMXF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
36%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
36%
Momentum
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
37%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
37%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
34%
Advances
ODDS (%)
Bullish Trend 9 days ago
59%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
52%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
25%
Aroon
ODDS (%)
Bullish Trend 2 days ago
51%
Bearish Trend 2 days ago
52%
View a ticker or compare two or three
Interact to see
Advertisement
SMMNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SSMXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GSLC122.891.06
+0.87%
Goldman Sachs ActiveBeta® US LgCp Eq ETF
BHK9.760.02
+0.21%
Blackrock Core BD TR
HTEC28.790.01
+0.05%
Robo Global® Hlthcare Tech & Innovt ETF
MGRO31.70N/A
N/A
VanEck Morningstar Wide Moat Growth ETF
BSMT22.75-0.01
-0.02%
Invesco BulletShares 2029 Muncpl Bd ETF

SMMNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMNY has been loosely correlated with SAUHY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SMMNY jumps, then SAUHY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMNY
1D Price
Change %
SMMNY100%
-1.31%
SAUHY - SMMNY
48%
Loosely correlated
-0.89%
CZMWY - SMMNY
44%
Loosely correlated
-4.93%
ESLOY - SMMNY
38%
Loosely correlated
-1.16%
ALC - SMMNY
37%
Loosely correlated
-1.70%
PHG - SMMNY
34%
Loosely correlated
-1.43%
More

SSMXF and

Correlation & Price change

A.I.dvisor tells us that SSMXF and OPK have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SSMXF and OPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SSMXF
1D Price
Change %
SSMXF100%
-6.43%
OPK - SSMXF
20%
Poorly correlated
+1.49%
SONVY - SSMXF
4%
Poorly correlated
-1.34%
SONVF - SSMXF
3%
Poorly correlated
N/A
SMMNY - SSMXF
3%
Poorly correlated
-1.31%
SNWV - SSMXF
3%
Poorly correlated
-0.22%
More